acs2024heal

Publisher

American Chemical Society (ACS)

Agreement ID acs2024heal
Agreement labeling ACS Read and Publish Agreement
Has the agreement been disclosed and published? Yes
URL https://diavgeia.gov.gr/doc/6ΕΝΨ46Ψ8ΧΒ-1Γ4
Agreement period 01/01/2024 – 12/31/2024
Consortia / Institution HEAL-Link (Hellenic Academic Libraries Link)
Country Greece
SIZE

Approximate range of annual corresponding author publications

106
Comments on size/article output 106 articles published in 2022 by HEAL-Link members
COSTS

How do the costs of the agreement relate to previous subscription-only agreements with the publisher?

Cost increase
Comments on cost development Cost increase includes an upgrade to all ACS journal publications
FINANCIAL SHIFT

Transformative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard?

Subscriptions partly converted to OA publishing fees
RISK SHARING

How do entitlements for open access publishing correlate to the anticipated article output? Which mechanisms for risk sharing have been agreed in cases of exceeding or not reaching the number of OA publishing entitlements?

Capped agreement. 94 hybrid and gold OA articles are covered in 2024, slightly below annual publishing output.
OA COVERAGE

Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement?

Yes
Are fully open access journals covered by the agreement? Yes
OA LICENSE CC-BY
ARTICLE TYPES
All article types except for additions, corrections, editorials
ACCESS COSTS

What is the approximate share of access related costs of the overall agreement?

More than 50%
Comments on access costs Clear distinction between reading costs and OA publishing costs
ACCESS COVERAGE

Are all read relevant journals covered by the agreement?

Yes
PERPETUAL ACCESS RIGHTS Yes
WORKFLOW ASSESSMENT Too early to assess
Comments on workflows It is the first RAP agreement with the publisher
OVERALL ASSESSMENT AND COMMENTS Too early to assess
Request contact to the licensee contact@esac-initiative.org